To include your compound in the COVID-19 Resource Center, submit it here.

Xenical orlistat: Marketed to treat obesity

In the double-blinded, placebo-controlled, Swedish XENDOS post-marketing trial in 3,304 Type II

Read the full 125 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE